Latest insights

Despite this wealth of information – or perhaps because of too much information? – maybe you are still uncertain.  We can help you organize and develop your views, in a 20-minute video. Our economists and strategists will try to clarify the economic and financial risks.

As governments continue to maintain low interest rates through the COVID-19 pandemic, and the correlation between asset classes remains high, the questions of diversification, income and attractive returns are firmly on investors’ agenda. You can now listen to the replay of our recent webinar which looked at the relevance of the multi asset absolute return approach in today’s investment markets and introduced our two risk-rated portfolios that meet your requirements.

ENGAGEMENT and VOTING play an important role in communicating our core values to the company in which we invest on behalf of our clients – promoting three conviction topics as priorities, namely : Energy transition, Fair working conditions, and Business ethics.

Lucia Meloni and Céline Deroux share their views about the changes we need to make in business and mindsets to reach a sustainable future.

Global equity markets had a difficult start to the year due to inflation and interest rate fears, and the Russian invasion in Ukraine, that has resulted in a spike of both energy and raw material prices. Unfortunately, also climate-related investments haven’t been spared from the global market turmoil.

As recently as the beginning of February, a total invasion still seemed unlikely. Since then, we have chosen to position for a potentially binary outcome, and have increased exposure to gold, the USD, the YEN, and the CHF, as well as to some commodities such as oil, while cutting our exposure to financials, reducing our equity exposure, and adding protection.

The Candriam Institute provides financial support to the PRecISion Medicine Institute. The PRISM technology aims to save an additional 200,000 lives each year by identifying the unique molecular characteristics of each patient's cancer. With this information, more targeted treatment can be applied at each step, improving survival rates.